Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group

K Krogsgaard, P Marcellin, C Trepo, P Berthelot, J M Sanchez-Tapias, M Bassendine, Anna Tuyet Nhung Tran, D Ouzan, H Ring-Larsen, Jacob Lindberg, J Enriquez, J P Benhamou, N Bindslev

47 Citationer (Scopus)

Abstract

The aim of this multicentre, randomised, controlled, clinical trial was to evaluate the effect of prednisolone followed by lymphoblastoid interferon treatment in chronic hepatitis B.
OriginalsprogEngelsk
TidsskriftJournal of Hepatology
Vol/bind25
Udgave nummer6
Sider (fra-til)803-13
Antal sider11
ISSN0168-8278
DOI
StatusUdgivet - dec. 1996

Fingeraftryk

Dyk ned i forskningsemnerne om 'Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group'. Sammen danner de et unikt fingeraftryk.

Citationsformater